
51.51 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 33.36 Today|||52-Week Range 68.68 | +11.18% Year-to-Date |
Ultragenyx (RARE) Posts Data From Osteogenesis Imperfecta Study 11:14am / Zacks.com - Paid Partner Content |
Previous close | 51.25 |
Today’s open | 54.44 |
Day’s range | 50.85 - 54.98 |
Volume | 37,937 |
Average volume (3 months) | 616,329 |
Market cap | $3.6B |
Earnings growth (last year) | -51.09% |
Earnings growth (this year) | +19.33% |
Earnings growth (next 5 years) | +86.06% |
Revenue growth (last year) | +3.39% |
P/E ratio | NM |
Price/Sales | 8.92 |
Price/Book | 10.10 |
Today’s change | Today’s % change | |
---|---|---|
CYTKCytokinetics Inc | -0.29 | -0.76% |
---- | ||
FOLDAmicus Therapeutics ... | +0.30 | +2.46% |
RETAReata Pharmaceutical... | +1.85 | +2.01% |
Next reporting date | August 3, 2023 |
EPS forecast (this quarter) | -$2.07 |
Annual revenue (last year) | $363.3M |
Annual profit (last year) | -$707.4M |
Net profit margin | -194.71% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Novato, California |